Abstract
Using various chromatography methods, five steroids and two brominated lipids (1-7), 3β- hydroxy-5-cholenic acid methyl ester, stigmasta-5,24(28)-dien-3β,29-diol, 24-methylenecholest-4-en- 3β,6β-diol, cholest-5-en-3β,7β-diol, 24-vinylcholest-5-en-3β,24-diol, xestospongiene A, and xestospongiene J, respectively, were isolated from the methanol extract of Vietnamese marine sponge Haliclona oculata (Linnaeus, 1759). Their structures were elucidated by 1D-, 2D-NMR, and ESI-MS spectra and in comparison with those reported in the literature. Compounds 1-4, 6, and 7 were reported from Chalinidae family for the first time. In addition, all compounds were evaluated for eight human cancer cell lines as HepG-2, KB, LU-1, MCF-7, LNCaP, HL- 60, SK-Mel2, and PC-3. As shown in results, compound 2 showed significant cytotoxic activities on KB and LU-1 cancer cell lines with the IC50 values ranging from 8.74 to 9.32 μM.
Keywords: Brominated lipid, cytotoxic, Haliclona oculata, steroid.
Letters in Organic Chemistry
Title:Cytotoxic Constituents from Vietnamese Marine Sponge Haliclona oculata (Linnaeus, 1759)
Volume: 12 Issue: 10
Author(s): Phan Van Kiem, Nguyen Thi Viet Thanh, Dan Thi Thuy Hang, Nguyen Thi Cuc, Nguyen Xuan Nhiem, Pham Hai Yen, Hoang Le Tuan Anh, Bui Huu Tai, Do Thi Thao and Chau Van Minh
Affiliation:
Keywords: Brominated lipid, cytotoxic, Haliclona oculata, steroid.
Abstract: Using various chromatography methods, five steroids and two brominated lipids (1-7), 3β- hydroxy-5-cholenic acid methyl ester, stigmasta-5,24(28)-dien-3β,29-diol, 24-methylenecholest-4-en- 3β,6β-diol, cholest-5-en-3β,7β-diol, 24-vinylcholest-5-en-3β,24-diol, xestospongiene A, and xestospongiene J, respectively, were isolated from the methanol extract of Vietnamese marine sponge Haliclona oculata (Linnaeus, 1759). Their structures were elucidated by 1D-, 2D-NMR, and ESI-MS spectra and in comparison with those reported in the literature. Compounds 1-4, 6, and 7 were reported from Chalinidae family for the first time. In addition, all compounds were evaluated for eight human cancer cell lines as HepG-2, KB, LU-1, MCF-7, LNCaP, HL- 60, SK-Mel2, and PC-3. As shown in results, compound 2 showed significant cytotoxic activities on KB and LU-1 cancer cell lines with the IC50 values ranging from 8.74 to 9.32 μM.
Export Options
About this article
Cite this article as:
Kiem Van Phan, Thanh Thi Viet Nguyen, Hang Thi Thuy Dan, Cuc Thi Nguyen, Nhiem Xuan Nguyen, Yen Hai Pham, Anh Le Tuan Hoang, Tai Huu Bui, Thao Thi Do and Minh Van Chau, Cytotoxic Constituents from Vietnamese Marine Sponge Haliclona oculata (Linnaeus, 1759), Letters in Organic Chemistry 2015; 12 (10) . https://dx.doi.org/10.2174/1570178612999150923120855
DOI https://dx.doi.org/10.2174/1570178612999150923120855 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Developments in Breast Tomosynthesis Imaging
Recent Patents on Medical Imaging New Robotic Technologies in Cancer Colon Screening
Clinical Cancer Drugs Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine
Current Medicinal Chemistry A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Separation of Ginseng Active Ingredients and their Roles in Cancer Metastasis Supplementary Therapy
Current Drug Metabolism Eph/Ephrin Signalling and Function in Oncogenesis: Lessons from Embryonic Development
Current Cancer Drug Targets ADDENDUM: Nutraceuticals for Protection and Healing of Gastrointestinal Mucosa. Romano M, Vitaglione P, Sellitto S, D’Argenio G. Curr Med Chem 2012, 19: 109-117.
Current Medicinal Chemistry Editorial (Thematic Issue: Modern Therapeutic Antibody Drug Discovery Technologies)
Current Drug Discovery Technologies Design, Synthesis and In Vitro Anti-Cancer Evaluation of Novel Derivatives of 2-(2-Methyl-1,5-diaryl-1H-pyrrol-3-yl)-2-oxo-N-(pyridin-3- yl)acetamide
Medicinal Chemistry Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic
Current Pharmaceutical Design Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design In Vitro Blood-Brain Barrier Models – Latest Advances and Therapeutic Applications in a Chronological Perspective
Mini-Reviews in Medicinal Chemistry Evolutionary Significance of Iodine
Current Chemical Biology Meet Our Editorial Board Member
The Natural Products Journal Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Current Drug Metabolism Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells
Current Stem Cell Research & Therapy Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level
Current Genomics The Role of Image Guided Radiotherapy in the Treatment of Soft Tissue Sarcoma
Current Cancer Therapy Reviews Stepwise Development of Biomimetic Chimeric Peptides for Gene Delivery
Protein & Peptide Letters